デフォルト表紙
市場調査レポート
商品コード
1471139

幹細胞市場:タイプ別、供給源別、用途別、エンドユーザー別-2024-2030年の世界予測

Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
幹細胞市場:タイプ別、供給源別、用途別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

幹細胞市場規模は2023年に136億6,000万米ドルと推計され、2024年には150億5,000万米ドルに達し、CAGR 10.79%で2030年には279億9,000万米ドルに達すると予測されています。

幹細胞市場は、研究開発、医療治療への応用に使用される様々な製品とサービスから構成されます。幹細胞株の販売、幹細胞の操作や分析に使用される機器、幹細胞バンキングや様々な疾患治療への応用に関するサービスなどが含まれます。幹細胞は、パーキンソン病、アルツハイマー病、糖尿病、心臓病などの再生医療に幅広く応用されています。また、様々ながん治療法の開発にも不可欠です。エンドユーザーには、研究機関、バイオテクノロジー企業、製薬会社、病院、幹細胞治療を患者に直接適用するクリニックなどが含まれます。幹細胞市場の成長を牽引しているのは、幹細胞研究への資金提供の増加、再生治療に対する需要の高まり、幹細胞治療をより身近で効果的なものにする技術の進歩などです。さらに、慢性疾患の罹患率が世界的に高まっていることから、革新的な治療法の開発が必要となり、幹細胞分野へのさらなる投資が促進されています。しかし、胚性幹細胞研究をめぐる倫理的な問題、幹細胞治療の高額な費用、十分な訓練を受けた人材の必要性、幹細胞治療の免疫拒絶反応の可能性、幹細胞製品の製造の複雑さなどが、幹細胞治療の普及を妨げています。一方、幹細胞市場における最も大きなビジネスチャンスは、新たな創薬プラットフォームの開発、個別化医療への応用、幹細胞の保存と解析における技術革新にあります。人工多能性幹細胞(iPS細胞)の治療応用の拡大や、組織・臓器再生のための幹細胞を利用した3Dバイオプリンティングの進歩も、探求すべき分野です。

主な市場の統計
基準年[2023] 136億6,000万米ドル
予測年 [2024] 150億5,000万米ドル
予測年 [2030] 279億9,000万米ドル
CAGR(%) 10.79%

タイプ倫理的・規制的ハードルの低さから成体幹細胞の利用が増加

成体幹細胞とは、胚発生後の全身に存在する未分化細胞です。骨髄、血液、脳、筋肉組織に存在します。成体幹細胞は多能性であり、複数の細胞タイプに発育することができますが、多能性幹細胞に比べると限定的です。成体幹細胞は、主に骨髄移植を通じて血液疾患を含む様々な疾患の治療に使用されます。ヒト胚性幹細胞(hESC)は、着床前胚の初期段階である胚盤胞の内部細胞群から供給されます。この多能性細胞は、生体のあらゆる種類の細胞に分化することができ、幅広い治療の可能性を提供します。あらゆる細胞型に分化する能力を持つhESCは、ヒトの初期発生、遺伝病、薬剤スクリーニングを理解する上で非常に貴重です。人工多能性幹細胞(iPSC)は、特定の遺伝子を導入することで、非多能性細胞(通常は成人の体細胞)から合成的に誘導される幹細胞の一種です。iPSCは、hESCに関連する倫理的な問題なしに、体内のあらゆる種類の細胞を生み出すことができるため、再生医療において有望視されています。幹細胞市場は多様性に富んでおり、それぞれの幹細胞がユニークな利点をもたらすと同時に、明確な課題に直面しています。成体幹細胞は広く利用されており、倫理的・規制的ハードルも低いが、分化の可能性は限られています。ヒト胚性幹細胞は、その多能性から莫大な治療の可能性を示していますが、多くの国で倫理的な議論や制限的な法律により、その利用が妨げられています。人工多能性幹細胞(幹細胞)は、新しい技術ではありますが、テーラーメイドの治療を提供し、倫理的制約を回避しますが、臨床応用における安全性と有効性を確保するためには、多大な研究開発が必要です。

応用診断モデル開発における幹細胞の応用拡大

診断分野は幹細胞応用の中でも極めて重要な分野であり、様々な疾患の早期発見やモニタリングに役立ちます。幹細胞は、ヒトの病気を模倣した診断モデルの開発に役立っており、研究者が病理学を理解し、新しい診断方法をテストすることを可能にしています。早期の正確な疾病診断の必要性が高まっており、幹細胞を含む革新的な診断ソリューションへの需要が高まっています。幹細胞は、創薬や薬剤開発において革新的な役割を果たします。ヒトに特化したモデルを提供することで、動物実験への依存度を下げ、薬剤反応の予測精度を向上させることができ、薬剤スクリーニングプロセスに革命をもたらす可能性を秘めています。コストを削減し、効果的な薬剤のパイプラインを増やすという製薬業界のプレッシャーが、幹細胞技術を創薬や薬剤開発に採用する原動力となっています。再生医療は幹細胞の最も有望な応用分野であり、損傷した組織や臓器を治癒し、これまで治療不可能であった疾患に対する解決策を提供する可能性があります。再生医療分野は、幹細胞のユニークな能力を活用し、従来の医療の限界を押し広げようとしています。再生医療の需要は患者主導型であり、多くの場合、脊髄損傷、火傷、心臓病など治療の選択肢が限られている状態に対するもので、新しい治療アプローチに対する大きなニーズを生み出しています。

地域別の洞察

米国では、幹細胞市場は研究への高水準の投資と強力な特許状況によって牽引されています。強固な規制枠組みのもと、研究機関や企業は幹細胞研究や臨床試験の最前線にいます。カナダの消費者は、幹細胞治療がもたらす可能性のある恩恵に対する知識を深めつつあり、需要の高まりを促しています。しかし、この市場の特徴として、規制当局の承認や特許取得に対する慎重なアプローチが挙げられます。南米の幹細胞市場はまだ発展途上にあるが、ヘルスケアインフラストラクチャへの投資の増加や医療ツーリズムの台頭により成長が期待されています。欧州は、確立された製薬産業が存在し、政府の政策も好意的であることから、幹細胞にとって重要な市場です。欧州連合(EU)の幹細胞研究に関する厳格な規制は、倫理的な実践と質の高い基準を保証し、資金提供や共同研究の機会は市場の成長に寄与しています。スイス、ドイツ、英国、フランスなどの国々では、国境を越えた数多くの提携関係や多額の資金援助があり、幹細胞研究に対して非常に協力的な雰囲気があります。中東では、特にサウジアラビアや医療技術革新で知られるイスラエルをはじめとする国々で、幹細胞研究への関心や投資が高まっています。アフリカの幹細胞市場はまだ発展途上ではあるが有望であり、南アフリカはその最前線にあります。APAC地域は、老齢人口の増加、医療費の増加、政府の支援政策などを背景に、幹細胞市場の急速な開拓が見られます。中国の幹細胞市場は、国家主導の取り組みとバイオテクノロジーへの多額の投資によって急速に拡大しています。日本は前向きな規制政策、特に再生医療に関する迅速な承認制度で知られています。日本の消費者が幹細胞治療に高い信頼を寄せているのは、政府による広範な支援と、技術の進歩を好む文化によるところが大きいです。インドの幹細胞市場は台頭しつつあり、研究イニシアチブの数が増加し、消費者の関心も高まっています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは幹細胞市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、幹細胞市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.幹細胞市場の市場規模および予測は?

2.幹細胞市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.幹細胞市場の技術動向と規制枠組みは?

4.幹細胞市場における主要ベンダーの市場シェアは?

5.幹細胞市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ゲノムに基づく高度な細胞解析技術のイントロダクション
      • 幹細胞治療の開発への投資増加
      • 幹細胞バンキングおよび処理に関連するインフラ開発
    • 抑制要因
      • 幹細胞治療にかかる高額な費用と熟練した人材の不足
    • 機会
      • iPSCの治療用途の拡大と、組織および臓器再生のための幹細胞を使用した3Dバイオプリンティングの進歩
      • パーソナライズ医療における幹細胞の応用拡大
    • 課題
      • 胚性幹細胞調査を取り巻く倫理的問題
  • 市場セグメンテーション分析
    • タイプ:倫理的および規制上のハードルが低いため、成人向け幹細胞の使用が増加している
    • 応用:診断モデルの開発における幹細胞の応用の拡大
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 幹細胞市場:タイプ別

  • 成体幹細胞
  • ヒト胚性幹細胞
  • 誘導多能性幹細胞

第7章 幹細胞市場:ソース別

  • 同種異系
  • 自家移植

第8章 幹細胞市場:用途別

  • 診断
  • 医薬品の発見と開発
  • 再生医療

第9章 幹細胞市場:エンドユーザー別

  • 学術調査機関
  • 病院と細胞バンク
  • 製薬・バイオテクノロジー企業

第10章 南北アメリカの幹細胞市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の幹細胞市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの幹細胞市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • QHP CapitalがApplied StemCellを買収
    • Stem Genomics、Pluristyxと多能性幹細胞製品およびサービスの提携
    • denovoMATRIX、初の幹細胞製品を発売し製品ポートフォリオを拡大
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. STEM CELLS MARKET DYNAMICS
  • FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELLS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 353. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 354. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 355. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 356. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 357. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 363. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 364. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 365. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 366. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 367. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 368. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 369. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 370. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 371. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 372. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 373. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 374. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 375. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 376. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 377. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 378. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 379. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 380. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2024-2030 (USD MILLION)
  • TABLE 381. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 382. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 383. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 384. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 385. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 386. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 387. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 388. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 389. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2023 (USD MILLION)
  • TABLE 390. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICI
目次
Product Code: MRR-434CCDA04CF2

[187 Pages Report] The Stem Cells Market size was estimated at USD 13.66 billion in 2023 and expected to reach USD 15.05 billion in 2024, at a CAGR 10.79% to reach USD 27.99 billion by 2030.

The stem cell market comprises various products and services used for the research, development, and application of stem cells in medical therapies. It includes the sale of stem cell lines, instruments used in the manipulation and analysis of stem cells, and services related to stem cell banking and therapeutic applications across various disease treatments. Stem cells find extensive applications in regenerative medicine for diseases such as Parkinson's, Alzheimer's, diabetes, and heart disease. They also are vital in developing various cancer treatments. End-users include research institutes, biotech companies, pharmaceutical corporations, hospitals, and clinics applying stem cell therapies directly to patients. Growth in the stem cell market is primarily driven by the increased funding for stem cell research, rising demand for regenerative treatment options, and advancements in technology that make stem cell therapies more accessible and effective. Additionally, the growing incidence rates of chronic diseases worldwide necessitate the development of innovative treatment approaches, fostering further investment in the stem cell sector. However, the adoption of stem cells is hindered by ethical issues covering embryonic stem cell research, the high costs of stem cell therapies, the need for adequately trained personnel, the potential immune rejection of stem cell therapies, and the complexity of manufacturing stem cell products. On the other hand, the most significant opportunities in the stem cell market lie in the development of new drug discovery platforms, applications in personalized medicine, and technological innovations in stem cell preservation and analysis. Expansion of the therapeutic applications of induced pluripotent stem cells (iPSCs) and advancements in 3D bioprinting utilizing stem cells for tissue and organ regeneration are other areas for exploration.

KEY MARKET STATISTICS
Base Year [2023] USD 13.66 billion
Estimated Year [2024] USD 15.05 billion
Forecast Year [2030] USD 27.99 billion
CAGR (%) 10.79%

Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles

Adult stem cells are undifferentiated cells located throughout the body after embryonic development. They can be discovered in bone marrow, blood, brain, and muscle tissues. Adult stem cells are multipotent, meaning they can develop into more than one cell type but are limited compared to pluripotent stem cells. Adult stem cells are primarily used to treat various diseases, including hematological conditions, through bone marrow transplants. Human embryonic stem cells (hESCs) are sourced from the internal cell group of a blastocyst, an early-stage pre-implantation embryo. These pluripotent cells can develop into any cell type of the body, offering broad therapeutic potential. With their ability to differentiate into any cell type, hESCs are immensely valuable for understanding early human development, genetic diseases, and drug screening. Induced pluripotent stem cells (iPSCs) are a kind of stem cell synthetically derived from non-pluripotent cells, typically adult somatic cells, by introducing certain genes. iPSCs hold promise in regenerative medicine because they can give rise to every cell type in the body without the ethical issues associated with hESCs. iPSCs are particularly promising for personalized medicine, as they can be derived from a patient's cells, reducing the risk of rejection. The stem cell market is diverse, with each type of stem cell offering unique benefits and facing distinct challenges. Adult stem cells are widely used and have fewer ethical and regulatory hurdles but offer limited differentiation potential. Human embryonic stem cells show vast therapeutic potential given their pluripotency, but their use is impaired by considerable ethical debates and restrictive legislation in many countries. Induced pluripotent stem cells, although a newer technology, provide tailored treatments and avoid ethical constraints but require significant research and development to ensure their safety and efficacy in clinical applications.

Application: Expanding the application of stem cells in developing diagnostic models

The diagnostic segment is a crucial area within stem cell applications, facilitating the early detection and monitoring of various diseases. Stem cells are instrumental in developing diagnostic models that mimic human diseases, enabling researchers to understand pathology and test new diagnostic methods. There's a growing need for accurate disease diagnosis early, subsequently increasing the demand for innovative diagnostic solutions involving stem cells. Stem cells play a transformative role in drug discovery and development. They have the potential to revolutionize the drug screening process by providing human-specific models, which can lower the dependency on animal testing and improve the predictive accuracy of drug responses. The pharmaceutical industry's pressure to reduce costs and increase the pipeline of effective drugs is a driving force behind the adoption of stem cell technologies in this drug discovery and development. Regenerative medicine is the most promising application of stem cells, potentially healing damaged tissues and organs and offering solutions for previously untreatable conditions. The regenerative medicine sector is pushing the boundaries of traditional medical treatments, harnessing the unique capabilities of stem cells. The demand in regenerative medicine is patient-driven, often for conditions with limited treatment options, such as spinal cord injuries, burns, and heart diseases, creating a significant need for novel therapeutic approaches.

Regional Insights

In the United States, the stem cell market is driven by high levels of investment in research and a strong patent landscape. With a robust regulatory framework, institutions and companies are at the forefront of stem cell research and clinical trials. Canadian consumers are becoming increasingly knowledgeable about the potential benefits of stem cell therapies, prompting a rise in demand. However, the market is also characterized by a cautious approach to regulatory approvals and patenting. The stem cell market in South America is still in the developmental phase but is expected to grow due to growing investment in healthcare infrastructure and rising medical tourism. Europe is a significant market for stem cells, with the presence of a well-established pharmaceutical industry and favorable government policies. The European Union's strict regulations on stem cell research ensure ethical practices and high-quality standards, while funding and collaboration opportunities contribute to the market growth. Countries such as Switzerland, Germany, the UK, and France showcase a highly collaborative atmosphere for stem cell research, with numerous cross-border partnerships and substantial funding. The Middle East has shown increasing interest in stem cell research and investment, particularly in countries, including Saudi Arabia, or Israel, which is known for its innovation in medical technology. Africa has a nascent but promising stem cell market, with South Africa at the forefront regarding research efforts and regulatory structure. The APAC region is witnessing rapid development in the stem cell market due to the increasing geriatric population, rising healthcare expenditure, and supportive government policies. China's stem cell market is expanding rapidly due to state-led initiatives and significant investment in biotechnology. Japan is known for its forward-looking regulatory policies, especially the fast-track approval system for regenerative medicine. Japanese consumers highly trust stem cell treatments, largely due to extensive government backing and a culture that favors technological advancement. India's stem cell market is emerging, with an increasing number of research initiatives and growing consumer interest.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Stem Cells Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stem Cells Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Athersys Inc., Becton, Dickinson and Company, Bioheart Inc., Biorestorative Therapies Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, GenScript Biotech Corporation, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd, Novartis AG, NuVasive Inc., Pluristyx, Inc., RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Adult Stem Cell
    • Human Embryonic Stem Cell
    • Induced Pluripotent Stem Cell
  • Source
    • Allogenic
    • Autologous
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Regenerative Medicines
      • Cardiology
      • Neurology
      • Oncology
  • End-user
    • Academic & Research Institutes
    • Hospitals & Cell Banks
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Stem Cells Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stem Cells Market?

3. What are the technology trends and regulatory frameworks in the Stem Cells Market?

4. What is the market share of the leading vendors in the Stem Cells Market?

5. Which modes and strategic moves are suitable for entering the Stem Cells Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of advanced Genome-based cell analysis techniques
      • 5.1.1.2. Increasing investment in the development of stem cell therapies
      • 5.1.1.3. Infrastructural development related to stem cell banking and processing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with stem cell therapies and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
      • 5.1.3.2. Growing applications of stem cells in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues surrounding embryonic stem cell research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles
    • 5.2.2. Application: Expanding the application of stem cells in developing diagnostic models
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Adult Stem Cell
  • 6.3. Human Embryonic Stem Cell
  • 6.4. Induced Pluripotent Stem Cell

7. Stem Cells Market, by Source

  • 7.1. Introduction
  • 7.2. Allogenic
  • 7.3. Autologous

8. Stem Cells Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicines

9. Stem Cells Market, by End-user

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Cell Banks
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QHP Capital Acquires Applied StemCell
    • 13.3.2. Stem Genomics, Pluristyx Partner for Pluripotent Stem Cell Products, Services
    • 13.3.3. denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio